PRDX4 and cardiovascular disorder: Specifically, sepsis [29], cancer [30] and cardiovascular disease [31] are candidate diseases where Prx4 measurement may be of particular use as they share redox and inflammatory dysregulation and frequently lack valid severity and risk assessment by non-invasive biomarkers.